Orchestra BioMed Holdings, Inc.
OBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61 | -$49 | -$34 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $8 | $3 | $0 |
| Change in WC | -$1 | -$3 | -$0 | $3 |
| Other Non-Cash | $0 | -$2 | $1 | $0 |
| Operating Cash Flow | -$51 | -$46 | -$29 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | -$1 | $0 | $0 | -$13 |
| Inv. Purchases | -$73 | -$142 | -$64 | -$0 |
| Inv. Sales/Matur. | $87 | $153 | $0 | $14 |
| Other Inv. Act. | $0 | $0 | $0 | $13 |
| Investing Cash Flow | $13 | $11 | -$64 | $13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $15 | -$11 | $4 | -$4 |
| Stock Issued | $15 | $0 | $110 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $57 | -$10 | $0 |
| Financing Cash Flow | $29 | $46 | $103 | -$4 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8 | $11 | $10 | -$10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $31 | $20 | $10 | $20 |
| End Cash | $22 | $31 | $20 | $10 |
| Free Cash Flow | -$51 | -$46 | -$30 | -$20 |